We're fighting the wrong battle. While the healthcare industry obsesses over CPT codes and telehealth parity laws, we've completely missed the real problem: we've taken a fundamentally broken payment system and simply moved it online.
I've spent the last twenty years deep in the trenches of benefits systems-watching telemedicine evolve from a novelty feature to an essential service. And here's what I've learned: every "solution" to telemedicine reimbursement just relocates the dysfunction from the waiting room to Zoom.
The conversation about reimbursement rates misses the point entirely. The real issue is that our entire payment infrastructure is fundamentally incompatible with what makes telemedicine actually valuable.
Why "Parity" Makes Everything Worse
Telehealth parity laws sound great on paper-finally, equal payment for virtual and in-person visits. Progressive policy at its finest, right?
Except it creates exactly the opposite of what we need.
Parity incentivizes providers to replicate the same rushed, episodic sick-care model online instead of leveraging what telemedicine does best: continuous, preventive, asynchronous care.
Look at how this plays out in practice:
- A dermatologist bills $150 for a 12-minute video consultation but gets nothing for reviewing photos asynchronously that could prevent three unnecessary office visits
- A psychiatrist gets paid for a 30-minute crisis intervention but not for the daily check-ins that would prevent the crisis in the first place
- A diabetes educator conducts a billable video session but can't get reimbursed for the text-based coaching that actually improves medication adherence
We've achieved "parity" by making telemedicine equally dysfunctional as traditional care. Mission accomplished?
The Invisible Value Problem
Here's the uncomfortable truth: everything that makes telemedicine clinically and economically valuable falls completely outside traditional reimbursement models.
Consider what telemedicine actually does best:
- Asynchronous monitoring that catches problems before they escalate-no CPT code exists
- Micro-consultations that prevent bigger issues-too brief to bill
- Relationship building over time that improves adherence-not classified as an "encounter"
- Environmental context from seeing patients' actual living conditions-can't be documented in ways that generate revenue
- Barrier elimination like removing transportation and time-off-work obstacles-completely invisible to claims systems
None of this fits into billing codes. None of it generates encounters. The entire reimbursement apparatus is blind to where the real value lives.
It's like paying the fire department only when buildings burn down, not when they prevent fires.
What Self-Funded Employers Miss in the Data
Self-funded employers love celebrating telemedicine as a cost-saver. Look at those claims data-a $45 virtual visit instead of a $450 ER visit. We're winning!
Except the data tells a more complicated story when you look beyond individual visit costs.
The Utilization Shell Game
Employees don't use telemedicine instead of other care. They use it in addition to other care. That $45 telehealth visit looks great until you track what happens next:
- $350 in follow-up lab work
- $180 specialist referral
- $90 monthly prescription
- $1,200 imaging study
Total impact on plan costs: an increase of $1,865, not a decrease of $405.
The Pharmacy Arbitrage Nobody Discusses
Here's something the industry doesn't talk about openly: many telemedicine platforms have figured out they can't make money on medical reimbursement alone. The visit might be cheap or even free, but prescription fulfillment-especially for lifestyle medications like hair loss treatments, ED drugs, weight loss, and anxiety meds-is where the real economics work.
This creates a troubling incentive structure. The business model rewards writing prescriptions over coaching lifestyle changes. A telemedicine platform makes more money prescribing metformin than helping someone modify their diet enough to avoid medication entirely.
For self-funded employers, telemedicine becomes a gateway drug to increased pharmacy spend-already the fastest-growing slice of healthcare costs.
The Prevention That Never Happens
Fee-for-service telemedicine doesn't prevent the $50,000 diabetic amputation or the $150,000 cardiac event. It just creates a cheaper way to manage symptoms leading up to those catastrophes.
The reimbursement model actively punishes the preventive protocols that would actually bend the cost curve.
The Remote Patient Monitoring Theater
Medicare introduced specific billing codes for remote patient monitoring-99453, 99454, 99457, 99458-that should enable reimbursement for continuous care management. Finally, payment for ongoing monitoring instead of just episodic visits!
But look at what's actually required:
- Monitoring must occur for at least 16 days per month
- Requires minimum 20 minutes of interactive communication
- Must be formally "ordered by" a physician
- Device must automatically upload data
Translation: the administrative overhead required to bill these codes often costs more than the reimbursement itself. Many providers don't even bother.
Meanwhile, the Apple Watch on someone's wrist collects more useful cardiovascular data than most paid RPM programs-and exactly none of it integrates with care protocols or triggers preventive interventions.
The Intelligence Layer Gap
Even when RPM gets reimbursed, there's a massive gap in what actually happens with all that data.
What insurance reimburses:
- Device rental fees
- Data collection
- Brief physician review time
What insurance doesn't reimburse:
- AI-driven early warning systems
- Integration with pharmacy adherence programs
- Automated care plan adjustments
- Predictive risk modeling
- Population health analytics
The reimbursement system pays for collecting data but not for the intelligence that makes data actionable. It's like paying someone to take your temperature but not to do anything when you have a fever.
The Licensing and Network Nightmare
Here's a reimbursement complexity that doesn't get nearly enough attention: state licensing requirements create a compliance nightmare that eats up a huge percentage of what gets paid.
A single telemedicine encounter might involve:
- A patient located in Missouri
- A provider licensed in California
- Claims processing through a Tennessee TPA
- An ERISA plan based in Delaware
- Medical necessity guidelines from another state entirely
Result? Administrative costs consume 30-40% of telemedicine reimbursement-money that could have paid for actual healthcare.
And here's the kicker: to manage these costs, TPAs and insurance carriers narrow telemedicine networks aggressively. But narrow networks completely undermine telemedicine's core promise-immediate access without geographic constraints.
What's the point of 24/7 virtual access if available providers don't know your history, can't see your records, and face pressure to minimize visit length to maximize billing volume?
The COVID Temporary Fix That's Coming Undone
During the pandemic, regulators created emergency flexibilities that actually made telemedicine work better:
- Cross-state practice without additional licensing
- Audio-only visits counted (not just video)
- Patients could be at home, not just at clinical sites
- Reimbursement parity for virtual visits
These changes dramatically improved access. Telemedicine utilization increased 38-fold in some specialties.
But here's the problem nobody wants to discuss: telehealth platforms built entire business models assuming these flexibilities would continue. Self-funded employers designed benefits around this expanded availability.
Many of these temporary policies could end with 60 days' notice. For platforms operating on thin margins, that's an existential threat.
The Mental Health Exception That Proves the Rule
Mental health telemedicine reimbursement has remained more stable than other specialties. Why?
- The provider shortage is so severe that access concerns override cost concerns
- Therapy sessions naturally fit the CPT code model-timed, synchronous, talk-based
- Privacy benefits from avoiding waiting rooms create obvious value even in fee-for-service
But this exception proves the rule: when telemedicine replicates traditional care delivery, reimbursement works fine. When it tries to be preventive and innovative, the payment system can't handle it.
Why Value-Based Care Hasn't Fixed This
In theory, capitated and value-based contracts should make telemedicine shine. The logic seems airtight:
- Prevent expensive complications → save money → keep the savings
- Continuous monitoring improves outcomes → earn quality bonuses
- Eliminate unnecessary visits → reduce costs → increase margins
Perfect alignment between incentives and outcomes, right?
Wrong. Value-based contracts rarely realize telemedicine ROI. Here's why:
The Attribution Problem
Which medical group or ACO "owns" the telemedicine encounter? If a patient has a video visit with a virtual provider, then sees their primary care physician, then visits a specialist-who gets credit for good outcomes? Who's responsible for the costs?
Nobody knows, so nobody wants to invest.
The Timing Mismatch
Preventive investments take 18-36 months to show meaningful savings. Most ACO contracts run year-to-year. By the time ROI appears, the contract has changed and savings get attributed to someone else entirely.
The Shared Savings Trap
Telemedicine costs show up immediately-technology implementation, provider training, platform fees. Savings appear in future periods and get distributed according to complex formulas that often leave the investing party with minimal returns.
The Capital Constraint
Fee-for-service margins are thin. Most providers lack capital for telehealth infrastructure when they're barely profitable on current operations.
Result: even in value-based models, providers default to fee-for-service thinking because reimbursement timing and attribution don't support investment in prevention.
The ERISA Complexity That Kills Innovation
Here's where benefits design gets legally complicated in ways that stop good ideas cold.
Direct Primary Care combined with telemedicine creates a completely different economic model:
- Employers pay a flat monthly fee per employee ($50-150)
- Employees get unlimited primary care access, virtual and in-person
- No claims, no coding, no insurance involvement
- Pure prevention focus because providers make the same amount whether you visit once or fifty times
This model eliminates fee-for-service dysfunction entirely. Providers stay focused on keeping you healthy because that's easier and more profitable than managing chronic disease.
But ERISA compliance becomes a maze:
- Is DPC a "group health plan" requiring Form 5500 filing?
- How does it coordinate with underlying major medical coverage?
- What disclosure requirements apply under ERISA Section 104?
- How do you handle COBRA and continuation coverage?
- Does it count toward Minimum Essential Coverage under ACA?
Most employers avoid this model not because it doesn't work clinically or economically, but because benefits administrators don't know how to implement it within ERISA guardrails.
Innovation dies in legal review.
The Carve-Out Strategy That Backfires
Many employers add telemedicine as a "carve-out"-a separate vendor sitting outside the main health plan. This seems smart on the surface: specialized service, lower cost, easy implementation.
But carve-outs create hidden problems that often eliminate the supposed savings:
Zero Data Integration
The telemedicine platform can't see claims history, medication lists, lab results, or care gaps. Every encounter starts from scratch. The telehealth provider has no idea what the primary care doctor prescribed last week.
Fragmented Care Delivery
Virtual providers and in-person physicians never communicate. The telehealth doctor prescribes a medication that dangerously interacts with what the PCP ordered. Nobody discovers this until the patient has an adverse event.
Duplicate Testing and Services
Employees get the same lab work ordered by multiple providers because systems don't talk to each other. The employer pays twice for the same test.
Reimbursement Finger-Pointing
When a telehealth visit triggers an in-person follow-up, who pays? The carve-out vendor says "not our responsibility." The main plan says "telemedicine should have handled it." The employee gets a surprise bill and calls HR furious.
The reimbursement savings on the telemedicine side get completely wiped out by increased waste and duplication everywhere else.
What the Smart Employers Are Actually Doing
The most sophisticated self-funded employers have stopped waiting for traditional insurance reimbursement to evolve. They're building alternative payment models that actually work.
Model One: Prevention-Based Capitation
Pay telemedicine providers a fixed per-member-per-month fee with outcomes-based bonuses:
- Reduce ER utilization by 15% → earn a 10% bonus
- Increase cancer screening compliance to 80% → earn a 15% bonus
- Improve diabetes HbA1c control across the population → earn a 20% bonus
This only works when the telemedicine provider has full claims data access, can drive pharmacy adherence, integrates with labs and diagnostics, and maintains longitudinal relationships with employees.
You're not buying telehealth visits. You're buying better health outcomes.
Model Two: Zero-Copay Telemedicine First
Make telemedicine completely free-no copay, no deductible-but structure it as the required first touchpoint:
- Before scheduling an in-person specialist → telemedicine triage required
- Before ER visit for non-emergencies → virtual assessment required
- Before expensive imaging → virtual review required
The economics are straightforward: every $0 telehealth visit that prevents a $1,500 ER visit saves $1,500 minus the telehealth cost (typically $40-60). You only need to prevent one ER visit per 30 employees annually to break even.
This works because you're not paying for reimbursement complexity. You're paying for utilization management with dramatically better user experience than traditional prior authorization.
Model Three: Integrated Digital Front Door Plus DPC
Combine several services into a single offering:
- Direct Primary Care (no insurance reimbursement)
- Telemedicine platform (unlimited access)
- Health coaching (included in membership)
- Medication adherence support (integrated)
Pay for everything via a single per-employee-per-month fee outside traditional insurance reimbursement. Then wrap this with a high-deductible plan for catastrophic coverage only.
The insight: by removing 80% of primary care transactions from the claims system entirely, you eliminate coding, billing, and reimbursement overhead while dramatically improving preventive care delivery.
The Health-to-Wealth Alternative
What if we could transcend the reimbursement model entirely?
Consider a fundamentally different approach to how value flows through the healthcare system.
Inverting the Incentive Structure
Traditional model:
Provider sees patient → files claim → gets paid for volume
Health-to-Wealth model:
Employee takes preventive action → earns immediate reward credit → receives automatic retirement contribution → provider gets outcomes bonus when claims decrease
The revolutionary shift: healthcare value flows to the employee based on prevention, not to the provider based on utilization.
This eliminates the core reimbursement dysfunction entirely. Nobody needs to argue about CPT codes or parity when the economic model rewards health outcomes instead of healthcare consumption.
The Data Advantage
Traditional telemedicine reimbursement generates basic claims data: CPT codes, diagnosis codes, visit dates. That's it.
A prevention-first system generates something completely different:
- Tracked preventive actions across 75+ behaviors
- Real behavioral adherence data, not billing codes
- Medication compliance patterns over time
- Longitudinal health trajectories for populations
- Readiness indicators for cost optimization opportunities
This data enables something impossible under traditional reimbursement: predictive optimization of the entire benefits ecosystem.
When you can demonstrate that moving specific Medicare-eligible employees to optimized coverage and restructuring pharmacy benefits will save $1.2M next year-backed by actual behavioral data, not actuarial projections-that's not a reimbursement rate negotiation anymore.
That's a fundamental redesign of where healthcare dollars flow.
The Uncomfortable Truth We Need to Face
Telemedicine reimbursement isn't broken because we haven't found the right CPT codes or achieved perfect parity across all settings and specialties.
It's broken because the entire fee-for-service reimbursement model is fundamentally incompatible with what makes telemedicine valuable.
Think about the core contradictions:
- We pay for synchronous visits when asynchronous care is often more effective and convenient
- We reimburse episodic encounters when continuous monitoring prevents problems before they escalate
- We code individual services when integrated care management creates the real value
- We bill for treatment when prevention would eliminate the need entirely
Every attempt to "fix" telemedicine reimbursement within the traditional framework is like trying to stream Netflix through telegraph wires. The infrastructure is fundamentally wrong for the application.
The real innovation isn't negotiating better reimbursement rates. It's building systems that eliminate the need for transactional reimbursement altogether.
What Different Stakeholders Should Do Now
For Self-Funded Employers
Stop asking: "What's our telemedicine reimbursement rate?"
Start asking:
- What percentage of telehealth visits lead to downstream claims increases versus decreases?
- Is telemedicine actually reducing our total cost of care, or just shifting costs around?
- What's happening to our pharmacy spend after telemedicine visits?
- Can our telemedicine vendor access claims data and actively close care gaps?
Action steps worth taking:
- Audit telemedicine ROI properly. Look at total cost of care impact over 12-18 months, not just per-visit reimbursement savings.
- Separate preventive from acute telemedicine. These are fundamentally different services with different value propositions. Consider paying for prevention outside the claims system entirely.
- Demand real data integration. If your telemedicine vendor can't access claims data and close care gaps, they're just another fragmented point solution adding complexity.
- Explore alternatives to fee-for-service. Prevention-based capitation, DPC hybrids, or outcomes-based bonuses align incentives far better than per-visit reimbursement.
For Brokers and Consultants
Stop selling telemedicine as a "cost saver" based solely on lower visit reimbursement rates. This approach is analytically lazy and sets false expectations with clients.
Start educating clients on what actually matters:
- Total cost of care impact measured properly
- Prevention metrics that drive long-term value
- Alternative payment models like DPC hybrids, prevention-based capitation, and outcomes bonuses
- ERISA compliance pathways for non-traditional models
Your real value isn't negotiating marginally better reimbursement rates with telehealth vendors. Your value is helping clients implement payment models that eliminate reimbursement friction entirely.
For TPAs and Carriers
You're in the best position to fix this systemic problem, but only if you're willing to disrupt your own revenue models.
Build reimbursement pathways for what actually creates value:
- Asynchronous care (the value lives in continuous monitoring, not just episodic visits)
- Bundled prevention services (not 47 separate CPT codes)
- Outcomes-based bonuses (let providers share in savings from prevented claims)
Create data infrastructure that enables:
- Telemedicine providers to access claims history and close identified care gaps
- Real-time integration between virtual and in-person care
- Proper measurement of total cost of care impact, not just per-encounter costs
Stop treating telehealth as a cost center that needs to be minimized. When structured correctly, it's the highest-ROI investment in the entire benefits ecosystem.
For Telemedicine Companies
Your current business model is probably unsustainable. Per-visit reimbursement in a race-to-the-bottom market doesn't build defensible businesses or improve health outcomes.
The platforms that will actually win long-term:
- Get paid for outcomes, not just encounters
- Integrate deeply with pharmacy, labs, and diagnostics
- Use data to drive genuine preventive protocols
- Partner directly with employers to reduce total cost of care
Stop optimizing for vanity metrics like visits per month or time to first appointment. Start optimizing for impact metrics: ER visits prevented, chronic disease management effectiveness, medication adherence rates, total cost trend.
The Future We Could Build
The most sophisticated benefits systems won't optimize telemedicine reimbursement within the existing framework.
They'll eliminate the need for transactional reimbursement entirely.
Imagine healthcare value flowing automatically from:
- Preventive health actions → immediate tangible rewards
- Sustained healthy behaviors → automatic long-term wealth building
- Reduced claims → lower costs for employers
- Better population health outcomes → success fees for providers
In this model, you don't argue about whether a virtual visit should reimburse at 80% or 100% of in-person rates. You've transcended the reimbursement model entirely.
This isn't theoretical fantasy. The building blocks exist today:
- Technology: AI-driven health tracking, integrated data platforms, behavioral incentive systems
- Legal framework: ERISA allows innovative plan designs; HIPAA permits necessary data sharing with proper safeguards
- Economic model: Prevention-based payments demonstrate better ROI than fee-for-service
- Consumer acceptance: Employees want healthcare that makes them healthier and wealthier simultaneously
What's missing isn't technological capability or regulatory permission.
What's missing is willingness to abandon a broken reimbursement model that everyone agrees is dysfunctional but nobody wants to disrupt first.
The Real Question
We keep trying to fix telemedicine reimbursement by adjusting rates, updating CPT codes, fighting legislative battles for parity, and negotiating better contracts.
But we're optimizing the wrong system entirely.
Fee-for-service reimbursement-whether delivered in person or virtually-creates incentives that are fundamentally misaligned with health. It rewards volume over value, treatment over prevention, complexity over simplicity, and encounters over outcomes.
Telemedicine had a genuine chance to break free from this dysfunction. Instead, we've digitized it with slightly better user experience.
The real opportunity isn't better reimbursement rates or more favorable coding.
It's building systems where:
- Prevention gets rewarded automatically
- Health data flows continuously and intelligently
- Incentives align across all stakeholders
- Value compounds over time rather than extracting at each transaction point
Until we move beyond fee-for-service reimbursement-whether in-person or virtual-we're just rearranging deck chairs on the Titanic while congratulating ourselves on the improved layout.
The question isn't how to reimburse telemedicine better within the existing framework.
The question is: what becomes possible when we stop needing transactional reimbursement altogether?
That's the conversation we should be having.